QT Vascular

Quantum Healthcare used to be called QT Vascular

Another EGM will be held on Dec 15 to vote on the removal of existing board directors.

Other than Mission Well which holds 11.35%, there are no other substantial shareholders of QT Vascular

The letter came after QT Vascular’s request for halt in the trading of its shares at 1.11pm on Nov 16.

QT Vascular says it intends to seek the approval of its shareholders on the move.

QT Vascular has announced the appointment of Kelvin Tong as its new Chief Financial Officer, succeeding previous CFO Randall H. Farwell.

SINGAPORE (June 29): QT Vascular specialises in the development of medical devices for treating vascular diseases, specifically catheters inserted into the body to clear blocked arteries. It has developed six products so far.

SINGAPORE (May 24): QT Vascular has entered into an asset purchase and option agreement to sell its non-drug coated coronary product line and related intellectual property (IP) licenses to Teleflex Life Sciences Unlimited Company and Teleflex Incorporated

SINGAPORE (Mar 1): QT Vascular, the maker of coronary products, announced that its FY17 losses have widened to US$25.9 million ($34.2 million) compared to US$12.0 million in FY16.

SINGAPORE (Jan 15): QT Vascular says it has raised $0.62 million from the capital commitment agreement entered into Gem Global.